Overall, the majority of breast cancers show increased CREB3L1 expression as compared to normal breast tissue, however ~30% of breast cancers show decreased CREB3L1 expression as a result of epigenetic silencing [13]. The gene discussed is CREB3L1; the disease is breast carcinoma.